321 results on '"Ardavanis, Alexandros"'
Search Results
2. The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis
3. Prospective, randomized, single-blinded, multi-center phase II trial of two HER2 peptide vaccines, GP2 and AE37, in breast cancer patients to prevent recurrence
4. A comprehensive clinicopathological evaluation of the differential expression of microRNA-331 in breast tumors and its diagnostic significance
5. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer
6. Loss of GAS5 tumour suppressor lncRNA: an independent molecular cancer biomarker for short-term relapse and progression in bladder cancer patients
7. Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study
8. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients
9. Epidemiological characteristics, clinical outcomes and management patterns of metastatic breast cancer patients in routine clinical care settings of Greece: Results from the EMERGE multicenter retrospective chart review study
10. Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients
11. Real-World Data on Cabozantinib in Advanced Osteosarcoma and Ewing Sarcoma Patients: A Study from the Hellenic Group of Sarcoma and Rare Cancers
12. Association between Intratumoral CD8+ T Cells with FoxP3+ and CD163+ Cells: A Potential Immune Intrinsic Negative Feedback Mechanism for Acquired Immune Resistance
13. Living with breast cancer: Patients’ journey within the Greek National Health System
14. BCL2L12: A promising molecular prognostic biomarker in breast cancer
15. Serum Concentration of Selected Angiogenesis-Related Molecules Differs among Molecular Subtypes, Body Mass Index and Menopausal Status in Breast Cancer Patients
16. Prevention of venous thromboembolism in ambulatory patients with active cancer: Results from ACT4CAT study.
17. Breakthrough Cancer Pain: An Observational Study of 1000 European Oncology Patients
18. Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival
19. A Multicenter, Prospective, Observational Study to Assess the Clinical Activity and Impact on Symptom Burden and Patients’ Quality of Life in Patients with Advanced Soft Tissue Sarcomas Treated with Trabectedin in a Real-World Setting in Greece
20. Second-line Paclitaxel/Carboplatin Versus Vinorelbine/Carboplatin in Patients Who Have Advanced Non–Small-Cell Lung Cancer Pretreated With Non–Platinum-Based Chemotherapy: A Multicenter Randomized Phase II Study
21. CureCancer Digital Platform in Clinical Oncology Practice Facilitates Patients’ Self-data Recording, Communicating, Treatment Adherence, “Distancing Interventions” During Covid-19 and Reduces Costs. A Feasibility and Satisfaction Study.
22. Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research Group
23. Prophylaxis of cancer‑associated venous thromboembolism with low‑molecular‑weight heparin‑tinzaparin: Real world evidence
24. The Addition of Mifamurtide To Adjuvant Chemotherapy For Early Osteosarcoma: A Retrospective Analysis From Greece.
25. Safety and Efficacy of RAD001 (Everolimus) Administered Upon Relapse During or After Adjuvant Treatment in Post-menopausal Women With Hormone Receptor Positive, HER2/neu Negative Locally Advanced or Metastatic Breast Cancer (CRAD001JGR08 “MELPOMENI” study)
26. CureCancer Digital Platform In The Routine Clinical Oncology Practice Facilitates Patients’ Self-Data Recording, Communicating With Health Care Professionals, Treatment Adherence And “Distancing Interventions” During Covid-19 And Reduces Costs. A Feasibility And Satisfaction Study*.
27. Kallikrein-related peptidase 6 (KLK6)gene expression in intracranial tumors
28. Human kallikrein-related peptidase 12 (KLK12) splice variants expression in breast cancer and their clinical impact
29. A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer
30. Clinical evaluation of PRMT1 gene expression in breast cancer
31. Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer
32. A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer
33. Quantitative analysis of BCL2 mRNA expression in nasopharyngeal carcinoma: an unfavorable and independent prognostic factor
34. A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
35. Leptomeningeal metastases from prostate cancer: an emerging clinical conundrum
36. Nivolumab in patients with rare head and neck carcinomas: A single center’s experience
37. Thromboprophylaxis in active cancer patients: Is it a controversial clinical issue or not? Preliminary results of ACT4CAT study.
38. Real-world multicenter, prospective study of the effects of nab-paclitaxel on clinical outcomes and quality of life of patients with metastatic breast cancer in Greece. The 'ABReast' study
39. Pegylated liposomal doxorubicin in combination with vinorelbine as salvage treatment in pretreated patients with advanced breast cancer: a multicentre phase II study
40. Comparison of HER2 Detection Methods Between Central and Regional Laboratories in Greece
41. The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro
42. Bevacizumab Therapy May Contribute to Irradiation Deferral in Patients With Breast Cancer and With Central Nervous System Metastases: Findings of a Case Series
43. Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design
44. Real-World Data on Thromboprophylaxis in Active Cancer Patients: Where Are We? Are We Getting There?
45. Cerebral metastasis from osteosarcoma: “Bone” in the brain
46. Acute Leriche Syndrome in Pancreatic Adenocarcinoma: A Case Report
47. ACT for prevention and prophylaxis of cancer-associated thrombosis (CAT).
48. Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents
49. Abstract P2-15-07: Real-world multicenter, prospective study of the effects ofnab-paclitaxel on clinical outcomes and quality of life of patients with metastatic breast cancer in Greece. The ‘ABReast’ study
50. Safety and Efficacy of Trastuzumab Every 3 Weeks Combined with Cytotoxic Chemotherapy in Patients with HER2-Positive Recurrent Breast Cancer: Findings from a Case Series
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.